U.S. Biotech Stock News

Over the last 7 days, the United States market has experienced a 1.5% decline, yet it has shown resilience with a 16% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider activity could offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.

Over the last 7 days, the United States market has experienced a 1.5% decline, although it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying stocks that are believed to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst broader market growth trends.

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In such an environment, growth stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and potential for significant revenue expansion.

Over the last 7 days, the United States market has dropped 1.5%, yet it remains up 16% over the past year, with earnings anticipated to grow by 17% per annum in the coming years. In such a landscape, identifying stocks with strong financials is crucial for investors seeking opportunities beyond traditional large-cap investments. Penny stocks, despite their somewhat outdated moniker, continue to intrigue investors due to their potential for value and growth; we'll explore several that stand...

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it has risen by 16% over the past year with earnings forecast to grow by 17% annually. In this dynamic environment, reliable dividend stocks can offer investors a steady income stream and potential for capital appreciation.

Anyone interested in Olema Pharmaceuticals, Inc. ( NASDAQ:OLMA ) should probably be aware that the Independent...

The fact that multiple Oculis Holding AG ( NASDAQ:OCS ) insiders offloaded a considerable amount of shares over the...

Kinder Morgan, Inc. ( NYSE:KMI ) stock is about to trade ex-dividend in four days. The ex-dividend date occurs one day...

Even though Allogene Therapeutics, Inc. ( NASDAQ:ALLO ) has fallen by 10% over the past week , insiders who sold...

As you might know, Las Vegas Sands Corp. ( NYSE:LVS ) last week released its latest second-quarter, and things did not...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Whilst it may not be a huge deal, we thought it was good to see that the Oak Valley Bancorp ( NASDAQ:OVLY ) Independent...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

We wouldn't blame Weatherford International plc ( NASDAQ:WFRD ) shareholders if they were a little worried about the...

Anyone interested in First United Corporation ( NASDAQ:FUNC ) should probably be aware that the Executive VP & Chief...

Consumer staples often sit quietly in portfolios while headlines focus on airlines, tech giants, and swings in oil prices. Yet when companies like Coca-Cola beat earnings expectations and raise their outlook, it can draw attention back to dependable dividend payers. With recent results from Boeing, JetBlue, UPS, and sharp moves in Brent oil creating fresh cross-currents for markets, this article looks at three large, established consumer staples stocks from our defensive dividend screener...

Centene stock barely flinched after earnings, slipping only 0.3% to about US$63.90, even though the headline numbers packed far more punch than that move suggests. The insurer lifted full year adjusted earnings per share guidance to more than US$4.80 and posted Q2 adjusted EPS of US$2.51, powered in part by risk adjustment settlements. For a company still wrestling with unprofitable trailing twelve month results, that kind of earnings power and guidance reset is the real story. The modest...

Xylem shares opened the morning after earnings up about 4% at US$124.97, a strong move for a steady water technology stock that usually trades on long contracts rather than headlines. The market is reacting to one clear message: profitability is the story this quarter. Record quarterly earnings per share of US$1.46 and an adjusted EBITDA margin of 23.3% put the focus firmly on margins rather than modest top line growth. For investors thinking beyond today’s bounce, the question now is how...

Liberty Latin America stock has delivered a 24.0% gain over the past year but is still down 37.7% over five years, which raises the question of whether the recent recovery is finally bringing the share price closer to what its fundamentals suggest. Over the last five years the stock has declined 37.7%, which indicates long term holders have not yet recovered from earlier share price weakness. The recent agreement to sell its stake in Peru based WOW Tel S.A.C. can help Liberty Latin America...

While it’s been a great week for Bankwell Financial Group, Inc. ( NASDAQ:BWFG ) shareholders after stock gained 11...

Enerpac Tool Group (EPAC) recently attracted investor attention after its board declared an annual cash dividend of $0.04 per share and approved a leadership change in the principal accounting officer role. See our latest analysis for Enerpac Tool Group. Recent news around Enerpac Tool Group, including the dividend declaration and the upcoming Investor Day at the New York Stock Exchange on 4 November 2026, comes as momentum has picked up again. The share price is at US$37.09, with a 1 day...

Fortrea Holdings, a clinical research company, recently announced it would release earnings after previously posting quarterly revenue of US$636.5 million, a 2.3% decline year on year that still surpassed analyst expectations. Investor attention is now centered on whether Fortrea can again outperform consensus as the market anticipates an 8.8% year-on-year revenue decline this quarter, reversing last year's growth in the same period. Next, we'll explore how this anticipated revenue decline,...

Vicor stock has delivered a very strong 320.2% return over the past year, yet the current checks on valuation suggest a company that no longer looks obviously cheap. The Discounted Cash Flow (DCF) intrinsic value estimate points to pricing that is roughly in line with fundamentals, while the broader valuation score leans more cautious. Over the past 12 months, Vicor has returned 320.2%, which puts extra focus on whether recent gains are already pricing in a lot of good news. Growing demand...

Some CSX Corporation ( NASDAQ:CSX ) shareholders may be a little concerned to see that the VP & Chief Accounting...